<DOC>
	<DOCNO>NCT03027648</DOCNO>
	<brief_summary>Objective : To investigate effect levonorgestrel-releasing intrauterine system ( LNG-IUS ) symptomatic adenomyosis . Methods : From December , 2006 December , 2014 , symptomatic patient adenomyosis diagnose ( dysmenorrhea and/or menorrhea ) transvaginal ultrasound outpatient inpatient clinic Peking Union Medical College Hospital give treatment LNG-IUS . Before placement LNG-IUS , follow period , parameter record prospectively , include carry status IUS , symptoms score dysmenorrhea , menstruation score , biochemical indicator , physical parameter , menstruation pattern adverse effect . Primary outcome measure : symptom score dysmenorrhea menorrhea Second outcome measure : carrying status IUS</brief_summary>
	<brief_title>Levonorgestrel-releasing Intrauterine System Treatment Symptomatic Adenomyosis</brief_title>
	<detailed_description />
	<mesh_term>Adenomyosis</mesh_term>
	<mesh_term>Levonorgestrel</mesh_term>
	<criteria>Women regular menses Adenomyosis diagnose via transvaginal ultrasound With severe dysmenorrhea ( VAS â‰¥ 7 ) and/or menorrhea ( pictorial chart score &gt; 100 ) Duration placement &gt; 12 month Size uterus physical examination less uterus 12week pregnancy Desire pregnancy lactation With diagnosis malignancy precancerous lesion Acceptance laparotomy Contraindication place levonorgestrelreleasing intrauterine system</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>levonorgestrel-releasing intrauterine system</keyword>
	<keyword>adenomyosis</keyword>
</DOC>